| Name | Title | Contact Details |
|---|
Marine Corps Personnel Support is a Quantico, VA-based company in the Business Services sector.
Omnicom Precision Marketing Group (OPMG) aligns Omnicoms global digital, data and CRM capabilities to deliver precisely targeted and meaningful customer experiences at scale. Using a universal framework of connected people, processes and platforms, OPMG provides services that include digital experience design and development, technology strategy and implementation, data-driven product / service design, CRM / loyalty strategy and activation, econometric and attribution modeling, technical and business consulting and change / program-management services. At the core of delivering these services is Omni, an advanced technology platform that combines advanced AI tools for content intelligence and automation with a powerful cultural insights engine and massively scaled data insights from first-, second- and third-party sources, including several proprietary Omnicom data partnerships. OPMGs 8,500 professionals operate in 40 offices in 26 markets and countries. OPMG is a division of Omnicom Group Inc (NYSE: OMC).
Steve's Place is a Davis, CA-based company in the Business Services sector.
Norm Marshall & Associates is a Sun Valley, CA-based company in the Business Services sector.
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.